All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Carolyn Jones, MD FACS 

Ara Vaporciyan, MD
Disclosure(s): AstraZeneca: Advisory Board (Ongoing)

Presentations

1. Late-Breaking: Impact of Surgical Factors on Event-Free Survival in the Randomized, Placebo-Controlled, Phase 3 KEYNOTE-671 Trial of Perioperative Pembrolizumab For Early-Stage Non-Small-Cell Lung Cancer
   Jonathan David Spicer, MD, PhD, FRCSC
   Disclosure(s): Amgen: Advisory Board (Ongoing), Speaker (Ongoing); Astrazeneca: Advisory Board (Ongoing), Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BMS: Advisory Board (Ongoing), Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); CLS Therapeutics: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Eisai: Advisory Board (Terminated); MSD: Advisory Board (Ongoing), Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Protalix Biotherapeutics: Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Regeneron: Advisory Board (Ongoing), Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Roche: Advisory Board (Terminated), Consultant (Terminated), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated); xenetic biosciences: Advisory Board (Ongoing), Consultant (Ongoing), Speaker (Ongoing)
    
2. Discussant
   Alessandro Brunelli, MD
    
3. Late-Breaking: Longitudinal Follow-up of Elderly Patients After Esophageal Cancer Resection in the Society of Thoracic Surgeons General Thoracic Surgery Database
   Justin Blasberg, MD
   Disclosure(s): Intuitive Surgical: Educational Proctor (Ongoing)
    
4. Late-Breaking: 2024 Update of The Society of Thoracic Surgeons Short-Term Pulmonary Resection and Esophagectomy Risk Models: More Inclusive with Improved Performance
   Christopher W. Seder, MD
    
5. Update from ABTS: General Directions and Maintenance of Certification
   Stephen C. Yang, MD FACS MAMSE
   Disclosure(s): DaVinci Intuitive Surgical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)